Indoleamine 2,3-dioxygenase in tumor induced tolerance

被引:17
|
作者
Liu Xiao-qian [1 ]
Wang Xin [1 ]
机构
[1] Shandong Univ, Dept Hematol, Prov Hosp, Jinan 250021, Shandong, Peoples R China
关键词
indoleamine 2,3-dioxygenase; immune tolerance; dendritic cells; regulatory T cells; 1-methyl-tryptophan; REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; DRAINING LYMPH-NODES; TRYPTOPHAN CATABOLISM; BACTERIAL LIPOPOLYSACCHARIDE; INCREASED POPULATIONS; PERIPHERAL-BLOOD; IDO; INHIBITION; EXPRESSION;
D O I
10.3760/cma.j.issn.0366-6999.2009.24.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To review the recent studies about the role of indoleamine 2,3-dioxygenase (IDO) in tumor induced tolerance. Data sources Published articles (1978-2009) on IDO and tumor induced tolerance were selected from Medline. Study selection Articles selected were relevant to development of IDO in tumor induced tolerance. Of all originally identified articles, 50 specially addressed the stated purpose. Results Recent work has revealed IDO at high levels in tumors and in tumor-draining lymph nodes and a close relationship between IDO activity and the regulatory T cells. Conclusion Up-regulation of IDO is proven to be a mechanism of acquired tolerance in tumors, in which the closely coupled positive feedback system between IDO and regulatory T cells may be considered to play an important role. Chin Med J 2009,122(24):3072-3077
引用
收藏
页码:3072 / 3077
页数:6
相关论文
共 50 条
  • [1] Indoleamine 2,3-dioxygenase in tumor induced tolerance
    LIU Xiaoqian and WANG Xin Department of Hematology Provincial Hospital Affiliated to Shandong University Jinan Shandong China Liu XQ and Wang X
    中华医学杂志(英文版), 2009, (24) : 3072 - 3077
  • [2] Indoleamine 2,3-dioxygenase and tumor-induced tolerance
    Munn, David H.
    Mellor, Andrew L.
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05): : 1147 - 1154
  • [3] Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation
    Munn, DH
    CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (02) : 220 - 225
  • [4] Indoleamine 2,3-Dioxygenase in Lung Allograft Tolerance
    Meloni, Federica
    Giuliano, Serena
    Solari, Nadia
    Draghi, Paola
    Miserere, Simona
    Bardoni, Anna Maria
    Salvini, Roberta
    Bini, Francesco
    Fietta, Anna Maria
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (11): : 1185 - 1192
  • [5] Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance
    Johnson, Theodore S.
    Munn, David H.
    IMMUNOLOGICAL INVESTIGATIONS, 2012, 41 (6-7) : 765 - 797
  • [6] INDOLEAMINE 2,3-DIOXYGENASE
    YOSHIDA, R
    HAYAISHI, O
    METHODS IN ENZYMOLOGY, 1987, 142 : 188 - 195
  • [7] Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
    Mellor, Andrew L.
    Lemos, Henrique
    Huang, Lei
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [8] Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer
    Ino, Kazuhiko
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2011, 23 (01) : 13 - 18
  • [9] Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase
    Ravishankar, Buvana
    Liu, Haiyun
    Shinde, Rahul
    Chandler, Phillip
    Baban, Babak
    Tanaka, Masato
    Munn, David H.
    Mellor, Andrew L.
    Karlsson, Mikael C. I.
    McGaha, Tracy L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (10) : 3909 - 3914
  • [10] Indoleamine 2,3-dioxygenase vaccination
    Andersen, Mads Hald
    Svane, Inge Marie
    ONCOIMMUNOLOGY, 2015, 4 (01) : 983770